Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases
2008
The epidemiology and clinical features of portal vein thrombosis: a multicentre study
2010
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Why portal hypertensive varices bleed and bleed: a hypothesis.
1995
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2015
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Cancer statistics, 2018
2018 Standout
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
The international normalized ratio according to Owren in liver disease: Interlaboratory assessment and determination of international sensitivity index
2013 StandoutNobel
Coagulation disorders and hemostasis in liver disease
2006
Identification of tissue transglutaminase as the autoantigen of celiac disease
1997 Standout
Hepatocellular carcinoma
2018 Standout
A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure
2011 Standout
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
Heparin-like Effect in Liver Disease and Liver Transplantation
2009
What we should know about portal vein thrombosis in cirrhotic patients: A changing perspective
2012
IgA antiendomysial antibody test
1991
Prevalence of the Activating JAK2 Tyrosine Kinase Mutation V617F in the Budd–Chiari Syndrome
2006
Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea
2000
Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis
2012
Oral Anticoagulant Therapy
2012 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
The Coagulopathy of Chronic Liver Disease
2011
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
2017
Acute-on chronic liver failure
2012
Prognostic Factors in Noncirrhotic Patients With Splanchnic Vein Thromboses
2007
Consensus on extra‐hepatic portal vein obstruction
2006
Liver biopsy†
2008
The Complex Role of Anticoagulation in Cirrhosis: An Updated Review of Where We Are and Where We Are Going
2016
Vascular disorders of the liver # †
2008 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity
2006 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Hemostatic Alterations in Liver Disease: A Review on Pathophysiology, Clinical Consequences, and Treatment
2007
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
2007
Chronic hepatitis B
2007 Standout
Prevention of First Bleeding in Cirrhosis
1992
Hypercoagulability in Patients With Chronic Noncirrhotic Portal Vein Thrombosis
2011
Management of Varices and Variceal Hemorrhage in Cirrhosis
2010
Chronic hepatitis B: Update 2009 #
2009 Standout
American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases
2017
Hemostasis and thrombosis in patients with liver disease: The ups and downs
2010
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Reporting prothrombin time results as international normalized ratios for patients with chronic liver disease
2010
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2000
The function of serotonin within the liver
2008
Mesenteric Venous Thrombosis
2013
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Updating Consensus in Portal Hypertension: Report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension
2000
Deep Vein Thrombosis and Pulmonary Embolism in Hospitalized Patients with Cirrhosis: A Nationwide Analysis
2011
Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis – A concise review
2010
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
2016
Vascular bed-specific thrombosis
2007
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Interlaboratory variability in assessment of the model of end‐stage liver disease score
2008
Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver Cirrhosis
2010
Fatty liver is an independent predictor of early carotid atherosclerosis
2016
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
2007
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event
2014 StandoutNobel
Hepatocellular Carcinoma
2019 Standout
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
2013
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
The Role of Interleukin 17 in Tumour Proliferation, Angiogenesis, and Metastasis
2014
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
An International Sensitivity Index (ISI) derived from patients with abnormal liver function improves agreement between INRs determined with different reagents
2010
NF-E2 p45 Is Important for Establishing Normal Function of Platelets
2013
Etiology, Management, and Outcome of the Budd-Chiari Syndrome
2009
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions
1997 Standout
Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders
2007
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Portal Hypertension and Its Complications
2008
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
How I treat rare venous thromboses
2008
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle
2010 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
AASLD position paper: Liver biopsy
2008
Thrombocytosis: Diagnostic Evaluation, Thrombotic Risk Stratification, and Risk-Based Management Strategies
2011
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Budd-Chiari Syndrome
2012
Works of Massimo Primignani being referenced
Prophylactic sclerotherapy in high-risk cirrhotics selected by endoscopic criteria
1991
The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study
2015
Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis
2006
Procoagulant imbalance in patients with non-alcoholic fatty liver disease
2014
Acute Portal Vein Thrombosis Unrelated to Cirrhosis: A Prospective Multicenter Follow-Up Study
2009
Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged
2009
NATURAL HISTORY OF PORTAL HYPERTENSION IN PATIENTS WITH CIRRHOSIS
2001
The international normalized ratio calibrated for cirrhosis (INRliver) normalizes prothrombin time results for model for end‐stage liver disease calculation†
2007
Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests†‡
2005
Natural history of portal hypertensive gastropathy in patients with liver cirrhosis
2000
Portal vein thrombosis, revisited
2009
Risk factors for thrombophilia in extrahepatic portal vein obstruction†
2005
TIPS for Budd-Chiari Syndrome: Long-Term Results and Prognostics Factors in 124 Patients
2008
Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: A randomized multicenter trial
1998
Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the MELD score
2009
High levels of factor VIII and risk of extra-hepatic portal vein obstruction
2009
An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma From Patients With Cirrhosis
2009
Prophylactic sclerotherapy in high-risk cirrhotics selected by endoscopic criteria
1991
Hypercoagulability in cirrhosis: causes and consequences
2011
Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma
2006
Thrombin generation in patients with cirrhosis: The role of platelets
2006
Endoscopic Treatments for Portal Hypertension
1999
High Frequency of Endothelial Colony Forming Cells Marks a Non-Active Myeloproliferative Neoplasm with High Risk of Splanchnic Vein Thrombosis
2010
Detection of the Imbalance of Procoagulant Versus Anticoagulant Factors in Cirrhosis by a Simple Laboratory Method
2010
MPL and JAK2 exon 12 mutations in patients with the Budd-Chiari syndrome or extrahepatic portal vein obstruction
2008
Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis
2013
WHY DO VARICES BLEED?
1992
The Course of Esophageal Varices in Patients with Hepatitis C Cirrhosis Responding to Interferon/ Ribavirin Therapy
2011
Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome
2009
Intrafamilial spread of hepatitis B virus infection
1981
Antibodies to Gliadin in Adult Coeliac Disease and Dermatitis herpetiformis
1984